Renovascular Hypertension Clinical Trial
Official title:
Phase I Study of Autologous Mesenchymal Stem Cells in the Treatment of Atherosclerotic Renal Artery Stenosis
To determine the safety and toxicity of intra-arterial infused autologous adipose derived mesenchymal stromal (stem) cells in patients with vascular occlusive disease of the kidney.
Individuals with unilateral arterial occlusive disease will be treated to injured kidney with autologous cells. ;
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT00868972 -
Renal Stenting With Distal Atheroembolic Protection
|
Phase 2/Phase 3 | |
Recruiting |
NCT05834803 -
Effects of Percutaneous Transluminal Renal Angioplasty of Atherosclerotic Renal Artery Stenosis in High-Risk Patients.
|
N/A | |
Completed |
NCT00006173 -
Magnetic Resonance Imaging for Evaluating Kidney Function
|
N/A |